Skip to content

Clinical trials

Phase 1 Hepatitis C, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 1 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20074
20083
20094
20102
20116
20126
20131
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Bader, Ted, M.D.2
Boehringer Ingelheim2
Bristol-Myers Squibb2
Hoffmann-La Roche2
Vertex Pharmaceuticals Incorporated2
Catherine Anne Chappell1
Duke University1
GlaxoSmithKline1
Intarcia Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic29
Hepatitis C12
Infections2
Recurrence2
Hemophilia A1
Liver Diseases1
Virus Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.